NYSE: UVE
UNIVERSAL INSURANCE HOLDINGS, INC.CIK 0000891166 · SIC 6331 · Fire, Marine & Casualty Insurance
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
revenue $427.0M, net income $59.2M. Universal Insurance Q2 2026: revenue +6.7% YoY, refinances debt to 2031, buybacks accelerate
5 material changes detected. Sign up free to read the summary.
Universal Insurance reports Q2 EPS of $2.04, up 68.6%, with 38.8% annualized ROCE
5 material changes detected. Sign up free to read the summary.
Partner
Trade UVE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Universal Insurance declares $0.16 quarterly dividend, payable August 7
1 material change detected. Sign up free to read the summary.
Universal Insurance refinances $100M debt at 7.75%, extending maturity to 2031
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Universal Insurance amends 2026 notes to cut redemption notice from 30 to 5 days
3 material changes detected. Sign up free to read the summary.
Universal Insurance secures $2.6B reinsurance tower with $45M retention for 2026-27
4 material changes detected. Sign up free to read the summary.
UVE: revenue $393.6M, net income $54.3M. UVE posts stronger Q1 results but tempers Florida reform optimism, faces 2026 debt maturity
5 material changes detected. Sign up free to read the summary.
Universal Insurance Holdings reports Q1 2026 earnings results
1 material change detected. Sign up free to read the summary.
Universal Insurance declares $0.16 dividend, sets Q1 earnings for April 23
2 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 30, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Income (Unaudited)
(in thousands, except per common share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| REVENUES | ||||
| Direct premiums written | 621,314 | 596,720 | 1,127,861 | 1,063,798 |
| Change in unearned premiums | (76,508) | (73,295) | (51,634) | (27,116) |
| Direct premiums earned | 544,806 | 523,425 | 1,076,227 | 1,036,682 |
| Ceded premiums earned | (167,533) | (163,232) | (342,052) | (320,768) |
| Premiums earned, net | 377,273 | 360,193 | 734,175 | 715,914 |
| Net investment income | 20,213 | 17,258 | 39,700 | 33,318 |
| Net realized gains (losses) on investments | 1,257 | 5,280 | 1,991 | 5,266 |
| Net change in unrealized gains (losses) on investments | 6,400 | (6,061) | 1,069 | (6,051) |
| Commission revenue | 13,780 | 15,854 | 28,511 | 32,129 |
| Policy fees | 6,039 | 5,603 | 11,021 | 10,096 |
| Other revenue | 2,071 | 2,014 | 4,131 | 4,336 |
| Total revenues | 427,033 | 400,141 | 820,598 | 795,008 |
| OPERATING COSTS AND EXPENSES | ||||
| Losses and loss adjustment expenses | 244,562 | 260,305 | 472,658 | 510,860 |
| Policy acquisition costs | 68,067 | 61,878 | 132,540 | 122,452 |
| Other operating costs and expenses | 32,794 | 29,964 | 60,503 | 56,634 |
| Total operating costs and expenses | 345,423 | 352,147 | 665,701 | 689,946 |
| Interest and amortization of debt issuance costs | 1,995 | 1,608 | 3,590 | 3,220 |
| INCOME (LOSS) BEFORE INCOME TAXES | 79,615 | 46,386 | 151,307 | 101,842 |
| Income tax expense (benefit) | 20,427 | 11,293 | 37,828 | 25,310 |
| NET INCOME (LOSS) | 59,188 | 35,093 | 113,479 | 76,532 |
| Basic earnings (loss) per common share | 2.14 | 1.25 | 4.11 | 2.73 |
| Weighted average common shares outstanding Basic | 27,618 | 27,972 | 27,588 | 28,066 |
| Diluted earnings (loss) per common share | 2.04 | 1.21 | 3.93 | 2.64 |
| Weighted average common shares outstanding Diluted | 29,043 | 29,072 | 28,901 | 28,977 |
| Cash dividend declared per common share | 0.16 | 0.16 | 0.32 | 0.32 |
Condensed Consolidated Balance Sheets
(in thousands, except per share data)
| Description | June 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| Available-for-sale debt securities, at fair value, net of allowance for credit loss of $881 and $631 (amortized cost: $1,553,900 and $1,466,145) | 1,506,146 | 1,431,028 |
| Equity securities, at fair value (cost: $113,037 and $87,326) | 111,829 | 85,420 |
| Other investments, at fair value (cost: $5,000 and $5,000) | 11,155 | 10,693 |
| Investment real estate, net | 5,367 | 5,463 |
| Total invested assets | 1,634,497 | 1,532,604 |
| Cash and cash equivalents | 532,160 | 408,868 |
| Restricted cash and cash equivalents | 68,635 | 68,970 |
| Prepaid reinsurance premiums | 562,104 | 291,031 |
| Reinsurance recoverables | 176,889 | 232,918 |
| Premiums receivable, net | 85,537 | 75,721 |
| Property and equipment, net | 48,640 | 49,349 |
| Deferred policy acquisition costs | 135,222 | 128,564 |
| Income taxes recoverable | 16,407 | — |
| Deferred income tax asset, net | 14,238 | 27,658 |
| Other assets | 31,835 | 24,012 |
| Total assets | 3,306,164 | 2,839,695 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| LIABILITIES: | ||
| Unpaid losses and loss adjustment expenses | 633,613 | 680,712 |
| Unearned premiums | 1,143,593 | 1,091,959 |
| Advance premium | 84,860 | 61,847 |
| Reinsurance payable, net | 627,776 | 257,242 |
| Commission payable | 33,379 | 26,307 |
| Income taxes payable | — | 28,554 |
| Other liabilities and accrued expenses | 47,936 | 41,558 |
| Debt, net of issuance costs | 97,852 | 100,481 |
| Total liabilities | 2,669,009 | 2,288,660 |
| Commitments and Contingencies (Note 12) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Cumulative convertible preferred stock, $0.01 par value | — | — |
| Authorized shares - 1,000; 10 issued and 10 outstanding | ||
| Minimum liquidation preference, $9.99 and $9.99 per share | ||
| Common stock, $0.01 par value | 483 | 482 |
| Authorized shares - 55,000; 48,388 and 48,234 issued, 27,830 and 28,008 outstanding, respectively | ||
| Treasury shares, at cost 20,558 and 20,226, respectively | (316,751) | (305,064) |
| Additional paid-in capital | 127,300 | 124,319 |
| Accumulated other comprehensive income (loss), net of taxes | (35,520) | (26,151) |
| Retained earnings | 861,643 | 757,449 |
| Total stockholders’ equity | 637,155 | 551,035 |
| Total liabilities and stockholders’ equity | 3,306,164 | 2,839,695 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net cash provided by (used in) operating activities | 255,899 | 292,992 |
| Cash flows from investing activities: | ||
| Proceeds from sale of property and equipment | 52 | 12 |
| Purchases of property and equipment | (2,482) | (2,204) |
| Purchases of equity securities | (60,581) | (18,431) |
| Purchases of available-for-sale debt securities | (271,990) | (210,052) |
| Proceeds from sales of equity securities | 37,495 | 3,446 |
| Proceeds from sales of available-for-sale debt securities | 88,519 | 25,476 |
| Proceeds from sale of private equity limited partnership | — | 11,463 |
| Maturities of available-for-sale debt securities | 102,291 | 89,778 |
| Net cash provided by (used in) investing activities | (106,696) | (100,512) |
| Cash flows from financing activities: | ||
| Debt issuance costs paid | (2,536) | — |
| Preferred stock dividend | (5) | (5) |
| Common stock dividend | (9,315) | (9,356) |
| Purchases of treasury stock inclusive of excise taxes paid | (11,687) | (7,427) |
| Payments related to tax withholding for share-based compensation | (1,967) | (1,290) |
| Repayment of debt | (100,736) | (735) |
| Proceeds from issuance of long-term debt | 100,000 | — |
| Net cash provided by (used in) financing activities | (26,246) | (18,813) |
| Cash and cash equivalents and restricted cash and cash equivalents: | ||
| Net increase (decrease) during the period | 122,957 | 173,667 |
| Balance, beginning of period | 477,838 | 262,076 |
| Balance, end of period | 600,795 | 435,743 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per common share data); (in thousands, except per share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗